LegisTrack
Back to all bills
HR 5178119th CongressIn Committee

Sickle Cell Disease Comprehensive Care Act

Introduced: Sep 8, 2025
Sponsor: Rep. Dunn, Neal P. [R-FL-2] (R-Florida)
Healthcare
Standard Summary
Comprehensive overview in 1-2 paragraphs

The Sickle Cell Disease Comprehensive Care Act would amend the Medicaid program (title XIX of the Social Security Act) to let states create sickle cell disease–focused health homes. Starting January 1, 2026, states could submit a sickle cell disease–focused State Plan Amendment (SPA) to provide comprehensive, coordinated care for eligible individuals with sickle cell disease through a health home. The bill requires that enrollees in such health homes receive dental and vision services, imposes reporting requirements on states, and directs the federal government to publish best practices for implementing these health homes. It also establishes definitions for “eligible individual with sickle cell disease” and “sickle cell disease” to ensure the program targets the intended population. In short, the bill seeks to integrate medical, dental, and vision care for people with sickle cell disease within Medicaid through a new, disease-focused health home model, with federal guidance and state-level implementation starting in 2026.

Key Points

  • 1Establishment of sickle cell disease–focused health homes: Beginning January 1, 2026, states may seek approval of a sickle cell disease–focused State Plan Amendment designed to provide health home services primarily to eligible individuals with sickle cell disease.
  • 2Mandatory dental and vision coverage: States with a approved sickle cell disease–focused SPA must ensure that eligible individuals with sickle cell disease enrolled in the health home receive dental and vision services, regardless of existing comparability rules or whether the state otherwise covers these services for other Medicaid beneficiaries.
  • 3Reporting requirements: For states operating a sickle cell disease health home, the state must submit a report (by the last day of the 8th fiscal-year quarter after the amendment is in effect) covering quality of care (with a focus on health outcomes), access to care, and total health care expenditures for eligible individuals with sickle cell disease served by the health home, using specified measures determined by the Secretary.
  • 4Best practices: By June 30, 2026, the Secretary must publicly share best practices for designing and implementing a sickle cell disease–focused SPA, based on clinical guidelines and input from providers and patient advocacy groups.
  • 5Definitions and scope: The bill defines an “eligible individual with sickle cell disease,” and “sickle cell disease,” and expands the health home framework to explicitly include sickle cell disease within the broader “chronic conditions” category and health home provisions.

Impact Areas

Primary group/area affected: Medicare/Medicaid beneficiaries with sickle cell disease enrolled in Medicaid, who would gain access to a coordinated health home that integrates medical, dental, and vision care.Secondary group/area affected: State Medicaid agencies (through SPAs), Medicaid providers (including hematologists, primary care, and dental/vision providers), and Medicaid managed care entities that administer or participate in health homes.Additional impacts:- Administrative and budget implications for states and HHS/CMS due to program design, reporting requirements, and potential changes in service utilization (e.g., increased preventive and coordinated care, potential shifts in hospital/ER use).- Increased data collection and quality measurement focused on sickle cell disease outcomes and care access.- Promotion of best practices and standardized approaches through CMS guidance, encouraging consistency across states in how these health homes are designed and implemented.
Generated by gpt-5-nano on Oct 8, 2025